Navigation Links
Global Pharmaceuticals & Medicine Manufacturing Industry Market Research Report from IBISWorld has Been Updated
Date:12/6/2013

Los Angeles, CA (PRWEB) December 06, 2013

Over the five years to 2013, the Global Pharmaceuticals and Medicine Manufacturing industry enjoyed steady growth, despite a number of changes to the industry's landscape. Industry revenue grew as a result of increased access to more comprehensive healthcare in developing countries and demographic shifts necessitating more healthcare expenditure. “The increasing number of global middle-class individuals has also translated into dramatic increases in demand for pharmaceuticals,” according to IBISWorld Industry Analyst Anna Son. Industry growth has been restrained, however, by the potent combination of a historically high level of patent expirations on blockbuster drugs, accelerating competition from generics and contributing to a depleted product pipeline, with fewer new medicines being marketed. Growing price pressures from governments and health insurance organizations around the globe has also placed significant strain on the industry.

During the five years to 2013, IBISWorld estimates that industry revenue will grow at an average annual rate of 3.7% to total $1.1 trillion. Over this year, the industry will continue to be challenged by key patent expirations and continued pricing pressures, amid changing healthcare access and funding issues. At the same time, emerging markets such as China, India and Brazil, will continue driving sales of pharmaceuticals. “Development in these markets is significantly exceeding the growth rates of more mature markets, such as the United States and Western Europe, which have to contend with increased regulation and significant changes in healthcare policy, due to various austerity measures and healthcare reforms,” says Son. However, despite these obstacles, revenue is forecast to grow 3.4% in 2013 overall.

In the short term, the industry is expected to continue its gradual transformation process. That is to say, emerging markets will continue to grow in importance as the geographic base of the industry gradually moves away from the traditional market powerhouses. Meanwhile, diversification strategies and merger and acquisition activity will remain key features that will characterize the industry's evolution. In addition, large-cap pharmaceutical companies will seek to acquire or partner with biotechnology companies with promising drug candidates, in order to bolster thinning pipelines.

For more information, visit IBISWorld’s Global Pharmaceuticals & Medicine Manufacturing industry report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld industry Report Key Topics

This industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms including ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be segmented into prescription-based (or ethical) products and over-the-counter medications. Industry products are predominantly distributed via wholesalers, and are then sold via pharmacies or distributed in hospitals.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on nearly every US and Global industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11396790.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural etc)- Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
2. M3 Global Research Expands Qualitative Research Department- Next Important Step in M3 Group Growth Strategy
3. Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013
4. Special Offer on Pharma Country Reports Bundle by GlobalData Available at MarketPublishers.com
5. BCC Research Publishes A New Report On Global Markets For Reproductive Technologies
6. BioPharm Insight Releases Quarterly Licensing Information on Global Drug Development
7. AMD Global Telemedicine Announces Integration of Encounter Management Software with Patient Records Management System
8. New report illustrates persistent global burden of anemia among high-risk populations
9. Matakina Launches Volumetric Breast Imaging Tools Built upon Globally Used, Multi-Vendor VolparaDensity Volumetric Breast Density Software
10. BCC Research Publishes A New Report On Global Markets For Waste And Wastewater Treatment
11. Hemodialysis Industry for Global and China 2013 Analysis in New Research Report at ChinaMarketResearchReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology: